Market for Vascular Repair and Reconstruction Segment to Grow at Highest CAGR during 2020-2027
According to the latest study on “South and Central America Extracellular Matrix Market Forecast to 2027- COVID-19 Impact and Regional Analysis - by application, and raw material,” the market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1% during 2020-2027. The report highlights trends prevailing in the South and Central America extracellular matrix market, and the drivers and restraints pertaining to the market growth.
Based on application, the South and Central America extracellular matrix market is segmented into vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair. The soft tissue repair segment held the largest share of the market in 2019. However, the vascular repair and reconstruction segment is estimated to register the highest CAGR during the forecast period. The growth of the vascular repair and reconstruction segment is driven by increasing accidents and trauma cases. Moreover, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).
The growth of the South and Central America extracellular matrix market is attributed to increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as, insufficient preservation of vasculature and extracellular matrix composition restrain the growth of the market. Organogenesis Inc., Integra Life Sciences Corporation, Mölnlycke Health Care AB, Anika Therapeutics, Inc., ACell Inc., MIROMATRIX MEDICAL Inc, Acera Surgical Inc., CorMatrix, Inc., Hollister Incorporated, MLM Biologics Inc., and Harbor MedTech, Inc are among the leading companies operating in the South and Central America extracellular matrix market.
The report segments South and Central America extracellular matrix market as follows:
By Application
By Raw Material
By Country
Reasons to Buy
According to the latest study on “South and Central America Extracellular Matrix Market Forecast to 2027- COVID-19 Impact and Regional Analysis - by application, and raw material,” the market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1% during 2020-2027. The report highlights trends prevailing in the South and Central America extracellular matrix market, and the drivers and restraints pertaining to the market growth.
Based on application, the South and Central America extracellular matrix market is segmented into vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair. The soft tissue repair segment held the largest share of the market in 2019. However, the vascular repair and reconstruction segment is estimated to register the highest CAGR during the forecast period. The growth of the vascular repair and reconstruction segment is driven by increasing accidents and trauma cases. Moreover, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).
The growth of the South and Central America extracellular matrix market is attributed to increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as, insufficient preservation of vasculature and extracellular matrix composition restrain the growth of the market. Organogenesis Inc., Integra Life Sciences Corporation, Mölnlycke Health Care AB, Anika Therapeutics, Inc., ACell Inc., MIROMATRIX MEDICAL Inc, Acera Surgical Inc., CorMatrix, Inc., Hollister Incorporated, MLM Biologics Inc., and Harbor MedTech, Inc are among the leading companies operating in the South and Central America extracellular matrix market.
The report segments South and Central America extracellular matrix market as follows:
By Application
- Vascular Repair and Reconstruction
- Dural Repair
- Wound Healing
- Cardiac Repair
- Pericardial Repair
- Soft Tissue Repair
By Raw Material
- Bovine
- Porcine
- Others
By Country
- Brazil
- Argentina
- Central America
- El Salvador
- Guatemala
- Rest of Central America
- RoSCAM
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America agriculture drone service market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America agriculture drone service market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging market.
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Extracellular Matrix Market - Market Landscape
5. South and Central America Extracellular Matrix Market Key Market Dynamics
6. Extracellular Matrix Market - South and Central America Analysis
7. South and Central America Extracellular Matrix Market Analysis - By Application
8. South and Central America Extracellular Matrix Market Analysis - By Raw Material
9. South and Central America Extracellular Matrix Market Revenue and Forecasts to 2027
10. Impact of COVID-19 Pandemic on South and Central America Extracellular Matrix Market
11. Extracellular Matrix Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Organogenesis Inc.
- Integra Life Sciences Corporation
- Mölnlycke Health Care AB
- Anika Therapeutics, Inc.
- ACell Inc.
- MIROMATRIX MEDICAL Inc
- Acera Surgical Inc., CorMatrix, Inc.
- Hollister Incorporated
- MLM Biologics Inc.
- Harbor MedTech, Inc.
